GSK’s Shingrix On Recovery Track In Q3 After Pandemic Slump

Newer Drugs Fuel HIV Sales Growth

 
• By Alaric DeArment
  
Business growth
Sales of GSK's Shingrix vaccine beat analyst expectations by more than 20% • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business